Recurrent disability progression endpoints in multiple sclerosis clinical trials.
Saved in:
| Title: | Recurrent disability progression endpoints in multiple sclerosis clinical trials. |
|---|---|
| Authors: | Bühler A; University of Waterloo, Waterloo, ON, Canada., Wolbers M; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Model F; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Wang Q; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Belachew S; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Manfrini M; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Lorscheider J; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research and Biomedical Engineering, University Hospital, University of Basel, Basel, Switzerland., Kappos L; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research and Biomedical Engineering, University Hospital, University of Basel, Basel, Switzerland., Beyersmann J; Ulm University, Ulm, Germany. |
| Source: | Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2023 Jan; Vol. 29 (1), pp. 130-139. Date of Electronic Publication: 2022 Sep 30. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1477-0970 |
|---|---|
| DOI: | 10.1177/13524585221125382 |
